The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for ...
Three of the top diabetes tech companies put forward new clinical data this week, making the case for their continuous glucose monitors and insulin pumps as they look to expand their reach among ...
If you use the Dexcom G7 continuous glucose monitoring system, you’ve long been able to view your blood sugar measurement on your Apple Watch – but you can now do so without your iPhone. Previously, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results